Fig. 5From: Identification of a small-molecule RPL11 mimetic that inhibits tumor growth by targeting MDM2-p53 pathwayMDM2 is required for S9-induced p53 activation, apoptosis and cell cycle arrest. A U2OS cells were transfected with MDM2 siRNA followed with described concentration of S9 treatment for 24Â h, MDM2, PARP cleavage and p53 protein levels were detected by western blot analysis. B The quantitation results of p53 and p21 western blotting images. C The quantitation results of cleaved PARP(CL)/total PARP(TL) western blotting images. D U2OS cells were transfected with MDM2 siRNA followed with described concentration of S9 treatment for 24Â h, stained with PI and analyzed by flow cytometryBack to article page